Ministry of Health and Population · Arab Republic of Egypt
Ministry of Health and Population100 Million Healthy Lives initiative
العربيةEnglishFrançais
InitiativesAll initiativesElderly Health Care Initiative"Our Children's Eyes, Our Future" InitiativeWomen's Health Support InitiativePremarital ScreeningCare for Children with Diabetes InitiativeMaternal and Fetal Health CareEarly Detection and Treatment of Cancer InitiativeInitiative for Early Detection and Treatment of Hearing Loss in NewbornsInitiative for Treating Children with Spinal Muscular AtrophyScreening and Treatment of Malnutrition among SchoolchildrenScreening and Treatment of Chronic Diseases and Early Detection of Kidney DiseaseEarly Detection of Genetic Diseases in NewbornsMental Health Support Initiative ("Your Health Is Happiness")Initiative for Mental Health Support and Early Intervention for Autism Spectrum DisordersThe Golden 1,000 Days Initiative for the Development of the Egyptian Family100 Days of Health
Health unitsAwarenessMedia centrePress releasesDocumentsFAQContact us
Press release

Latest medical tests unveiled and drug treatment provided to 4,864 liver cancer patients.

25 August 2025Ministry of Health and Population
Latest medical tests unveiled and drug treatment provided to 4,864 liver cancer patients.
Listening time ≈ 3 minutes
Speed

The Ministry of Health and Population, represented by the National Committee for the Control of Viral Hepatitis, announced the enrolment of 118,208 liver cirrhosis patients in the initiative for the early detection and treatment of liver cancer, during the two years since the initiative was launched in March 2022, which contributes to protecting them from developing liver cancer, saving patients' lives and ensuring they receive treatment quickly.

Dr. Hossam Abdel Ghaffar, the official spokesperson of the Ministry of Health and Population, pointed out that most of the cases found to have liver cancer under the initiative are in the fourth stage of the disease, for which liver cancer drugs are the only treatment option according to international recommendations, which necessitated the creation of a liver cancer treatment system.

"Abdel Ghaffar" noted that drug treatment has been provided to 4,864 liver cancer patients under the initiative, and immunotherapy to 286 patients, explaining that medicines are dispensed to "liver cancer" patients during their first visit after being referred for assessment, through 22 multidisciplinary clinics within the viral hepatitis treatment units that bring together specialities (hepatology, oncology, interventional radiology, surgery) to assess the case and determine the best type of treatment, whether drug-based or surgical.

For his part, Dr. Mohamed Abdallah, head of the Central Administration for Integrated Health Care and director of the initiative for the early detection and treatment of liver cancer, revealed that the detection system has been supported by adding the "PIVKA II" test as one of the programme's standard tests as of March 2024, with implementation in 10 governorates and its rollout to all governorates under way, in addition to supporting the system with 30 modern ultrasound machines to raise diagnostic quality, and 6 FibroScan machines to measure degrees of fibrosis.

He pointed to the automation of the initiative's work, the updating of the database, and the use of the DHIS2 system, a tool for collecting, managing and analysing data in the health field.

"Abdallah" stated that liver cirrhosis patients are received at the viral hepatitis units, where their health condition is assessed and their medical reports reviewed. Ultrasound screening services and tumour marker tests are also provided periodically every 4 months to liver cirrhosis patients through 58 viral hepatitis units located in hospitals affiliated with the Ministry of Health and university hospitals.

It is worth noting that the viral hepatitis units operate every day of the week except Friday, from (9 a.m. to 12 noon), and citizens' enquiries are received on the hotline 15335.